Singapore COVID-19 data cross-validation by the Gaidai reliability method.

Area of Science:

• Public Health
• Biostatistics
• Epidemiology

Background:

• Novel coronavirus infection (COVID-19) presents a significant global public health challenge.
• Existing methods may not fully capture the complexities of multi-regional health system risks.
• Accurate risk assessment is crucial for effective public health preparedness and response.

Purpose of the Study:

• To introduce and validate a novel bio-reliability approach for assessing public health system risks.
• To evaluate the risks of excessive coronavirus death rates within specific timeframes and regions.
• To benchmark the novel Gaidai bio-reliability method against established statistical techniques.

Main Methods:

• Development and application of a novel spatiotemporal bio-reliability method.
• Cross-validation of the novel method against the bivariate Weibull method using raw clinical data.
• Analysis of multi-regional environmental and health system data over a representative time period.

Main Results:

• The novel Gaidai bio-reliability method provides accurate assessment of national public health system risks.
• The spatiotemporal approach was successfully cross-validated, demonstrating its reliability.
• The method allows for long-term future death rate risk assessment and confidence interval generation.

Conclusions:

• The novel bio-reliability approach is suitable for multi-regional environmental and health systems.
• This methodology offers a valuable tool for public health applications beyond COVID-19.
• Accurate risk assessment is essential for strengthening national public health systems against future threats.